Development of the Oncotype DX®
Breast Recurrence Score™

The Oncotype DX Breast Recurrence Score was developed using a rigorous four-step process.

Breast Cancer Rigorous Development

THE BREAST RECURRENCE SCORE INCORPORATES A UNIQUE SET OF GENES THAT PROVIDE BOTH PROGNOSTIC AND PREDICTIVE INFORMATION, SETTING IT APART FROM ANY OTHER GENOMIC TEST FOR EARLY-STAGE INVASIVE BREAST CANCER

Breast Cancer Genes

 

REFERENCE
1. Cronin et al. Am J Pathol. 2004.
Next: Extensive Validation